Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183001 · ClinicalTrials.gov registry record · Phase 3
Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification
A Phase 3 study of Inflammation and Osteoporosis, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 3
- Development phase
- 452
- Enrollment target
- 1
- Study location
NCT00183001: Completed Phase 3 study of Inflammation and Osteoporosis, sponsored by National Institute on Aging (NIA).
NCT00183001 is a Phase 3 study of Inflammation and Osteoporosis that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 452 participants, above the 285-participant average among 132 other Inflammation trials with a reported enrollment target (59% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183001, a Phase 3 study of Inflammation and Osteoporosis, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 452 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if supplemental vitamin K will reduce age-related bone loss in elderly men and women above that achieved by supplementation.
Conditions Studied
Interventions
- DRUG Vitamin K
Study Locations (1)
Massachusetts
- Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2001-10 |
| Est. Completion | 2006-10 |
| Phase | Phase 3 |
What the finished NCT00183001 record still lists
NCT00183001 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, above the 285-participant average among 132 other Inflammation trials with a reported enrollment target (59% higher).
The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Vitamin K is the first listed.
NCT00183001 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00183001 about?
NCT00183001 is a clinical study titled "Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification". The purpose of this study is to determine if supplemental vitamin K will reduce age-related bone loss in elderly men and women above that achieved by supplementation.
What is the current status of trial NCT00183001?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 452 participants. The study started on 2001-10. Estimated completion is 2006-10.
What conditions does trial NCT00183001 study?
This clinical trial studies the following conditions: Inflammation, Osteoporosis, Vascular Calcification.
What interventions are being tested in trial NCT00183001?
The interventions under investigation include: Vitamin K (DRUG).
Who is sponsoring clinical trial NCT00183001?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00183001 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00183001's enrollment target sits among peer trials
452 8th of 132 higher than 125 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation
COMPLETED · Phase 3
-
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
COMPLETED · Phase 3
-
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
COMPLETED · Phase 3
-
Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia